ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.3100
-0.0100 (-3.13%)
Aug 14, 2026, 11:12 AM AEST
ImExHS Market Cap
ImExHS has a market cap or net worth of 16.86 million as of August 14, 2026. Its market cap has increased by 25.73% in one year.
Market Cap
16.86M
Enterprise Value
14.13M
Revenue
28.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
ChartMarket Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 16.86M, a decrease of -32.53%. That is a compound annual growth rate of -4.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 16.86M | -22.01% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 435.98M |
| Healius | 290.46M |
| Monash IVF Group | 270.80M |
| Cryosite | 61.01M |
| Microba Life Sciences | 34.42M |
| Rhythm Biosciences | 28.66M |
| INOVIQ | 27.45M |
| BCAL Diagnostics | 20.65M |